ENZO BIOCHEM INC (ENZ)
US2941001024 - Common Stock
| TTM (2024-1-31) | 2023 (2023-7-31) | 2022 (2022-7-31) | 2021 (2021-7-31) | 2020 (2020-7-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | 32.57M | 20.29M | -18.26M | 7.88M | -28.52M | |||
| Depreciation Amortization | 1.79M | 2.68M | 2.83M | 2.65M | 2.78M | |||
| Income Taxes - Deferred | N/A | N/A | N/A | N/A | N/A | |||
| Change In Working Capital | -1.71M | 18.56M | -6.83M | -4.77M | 7.96M | |||
| Interest Paid | 1.32M | 1.25M | 231.00K | 237.00K | 270.00K | |||
| Taxes Paid | N/A | N/A | N/A | N/A | N/A | |||
| Other non cash items | -77.04M | -78.50M | 5.68M | -5.37M | 600.00K | |||
| OPERATING CASH FLOW | -44.40M | -36.98M | -16.59M | 387.00K | -17.18M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -1.52M | -2.76M | -3.47M | -4.44M | -2.17M | |||
| Other Investing Activity | N/A | 101.74M | 28.70M | -30.06M | 0.00 | |||
| INVESTING CASH FLOW | 100.22M | 98.98M | 25.22M | -34.50M | -2.17M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -1.05M | -1.14M | -269.00K | -339.00K | 7.00M | |||
| Stock Issued/Repurchased | N/A | 400.00K | 28.00K | 97.00K | 0.00 | |||
| Other Financing Activity | N/A | -389.00K | N/A | 0.00 | 0.00 | |||
| FINANCING CASH FLOW | -1.51M | -1.13M | -241.00K | -242.00K | 7.00M | |||
| Exchange Rate Effect | -130.00K | -109.00K | -63.00K | 11.00K | 70.00K | |||
| CHANGE IN CASH | 54.19M | 60.77M | 8.33M | -34.34M | -12.28M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -44.40M | -36.98M | -16.59M | 387.00K | -17.18M | |||
| Capital Expenditure | -1.52M | -2.76M | -3.47M | -4.44M | -2.17M | |||
| FREE CASH FLOW | -45.91M | -39.74M | -20.06M | -4.05M | -19.35M | |||
All data in USD